Treatment Efficacy Score—continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials

I-SPY Consortium

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Treatment Efficacy Score—continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials'. Together they form a unique fingerprint.

Medicine & Life Sciences